Abatacept for the Treatment of Giant Cell Arteritis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(9 sites)

United States

Mayo Clinic, Rochester, Minnesota

Hospital for Special Surgery, New York, New York

Cleveland Clinic, Cleveland, Ohio

University of Pennsylvania, Philadelphia, Pennsylvania

Vanderbilt University, Nashville, Tennessee

Canada

University of British Columbia, Vancouver, British Columbia

St. Joseph's Healthcare, Hamilton, Ontario

Mount Sinai Hospital, Toronto, Ontario

Hôpital du Sacré-Coeur de Montréal Université de Montréal, Montreal, Quebec